Intratumoral Cisplatin for Resectable NSCLC
NCT04809103
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
cis-diamminedichloroplatinum
Sponsor
University of Vermont
Collaborators
[object Object]